APA Alıntı

Ikink, G. J., Boer, M., Bakker, E. R. M., Vendel-Zwaagstra, A., Klijn, C., ten Hoeve, J., . . . Hilkens, J. (2018). Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance. Oncogene.

Chicago Stili Alıntı

Ikink, Gerjon J., Mandy Boer, Elvira R. M. Bakker, Annabel Vendel-Zwaagstra, Chris Klijn, Jelle ten Hoeve, Jos Jonkers, Lodewyk F. Wessels, ve John Hilkens. "Insertional Mutagenesis in a HER2-positive Breast Cancer Model Reveals ERAS As a Driver of Cancer and Therapy Resistance." Oncogene 2018.

MLA Alıntı

Ikink, Gerjon J., et al. "Insertional Mutagenesis in a HER2-positive Breast Cancer Model Reveals ERAS As a Driver of Cancer and Therapy Resistance." Oncogene 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..